Laura Rosenberg
About Laura Rosenberg
Laura Rosenberg is a Senior Research Associate I at Alkermes with a background in adaptive immunity, oncology, and inflammation biology, currently pursuing a PhD at Icahn School of Medicine at Mount Sinai.
Current Position at Alkermes
Laura Rosenberg is currently serving as a Senior Research Associate I at Alkermes. She began her role in February 2021 and works in Waltham, Massachusetts. Her position involves in-depth research responsibilities likely involving the development and implementation of experimental protocols, data analysis, and collaboration with cross-functional teams.
Previous Roles at Alkermes
Before her current role, Laura Rosenberg worked at Alkermes as a Research Associate II from 2019 to 2021. During her two-year tenure, she developed her expertise in experimental procedures and contributed to various research projects in the organization.
Experience in Academic and Industry Settings
Laura Rosenberg has accumulated extensive experience in both academic and industry environments. She has held multiple co-op and internship roles at Brigham and Women's Hospital - Harvard Medical School, Compass Therapeutics LLC, Jounce Therapeutics, Inc., and Gilead Sciences. Her diverse background has provided her with a comprehensive understanding of adaptive immunity, oncology, and inflammation biology.
Educational Background
Laura Rosenberg earned her Bachelor's degree in Biology from Northeastern University, where she studied from 2014 to 2019. Additionally, she is currently pursuing a PhD at the Icahn School of Medicine at Mount Sinai. Her academic achievements reflect a solid foundation in the biological sciences.
Notable Research Positions
Throughout her career, Laura Rosenberg has gained diverse research experience. She worked as a Sleep Lab Co-op at Brigham and Women's Hospital - Harvard Medical School for nine months, as an Adaptive Immunity Co-op at Compass Therapeutics LLC for five months, as a Preclinical Development Co-op at Jounce Therapeutics, Inc. for five months, and as an Oncology and Inflammation Biology Intern at Gilead Sciences for three months. These roles have bolstered her expertise in various scientific research domains.